Silencing of the Mutant Huntingtin Gene Through CRISPR-Cas9 Improves the Mitochondrial Biomarkers in an in Vitro Model of Huntington’s Disease
Cell Transplantation - United States
doi 10.1177/0963689719840662
Full Text
Open PDFAbstract
Available in full text
Date
April 1, 2019
Authors
Publisher
SAGE Publications